Immix Biopharma Investor Presentation Deck

Neurotoxicity Restricts CAR-T Adoption Parkinson's Like Symptoms (can develop after 3 months) Limited Hospital Access (can only be dosed in 5% hospitals in the US) CAR-T Neurotoxicity Long Hospital Stay (average -14 days) Patient Deaths (On FDA Appproval Labels) ●●● IMMIX S BIOPHARMA 4

View entire presentation